Literature DB >> 22617426

Transcription: another mark in the tail.

Jesper Q Svejstrup1.   

Abstract

The C-terminal domain (CTD) of the largest RNA polymerase II (RNAPII) subunit undergoes dynamic phosphorylation to support transcription-associated events and drive the transcription cycle. In mammalian cells, it comprises 52 repeats of the heptapeptide sequence Tyr(1)–Ser(2)–Pro(3)–Thr(4)–Ser(5)–Pro(6)–Ser(7). While important functions for Ser(2)-, Ser(5)-, and Ser(7)-phosphorylation have previously been described, a new report in The EMBO Journal now suggests an unexpectedly crucial role for Thr(4) phosphorylation as well.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617426      PMCID: PMC3380221          DOI: 10.1038/emboj.2012.154

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  12 in total

1.  Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product.

Authors:  R Baskaran; G G Chiang; T Mysliwiec; G D Kruh; J Y Wang
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

Review 2.  Structure of eukaryotic RNA polymerases.

Authors:  P Cramer; K-J Armache; S Baumli; S Benkert; F Brueckner; C Buchen; G E Damsma; S Dengl; S R Geiger; A J Jasiak; A Jawhari; S Jennebach; T Kamenski; H Kettenberger; C-D Kuhn; E Lehmann; K Leike; J F Sydow; A Vannini
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

3.  Level of the RNA polymerase II in the fission yeast stays constant but phosphorylation of its carboxyl terminal domain varies depending on the phase and rate of cell growth.

Authors:  Hitomi Sakurai; Akira Ishihama
Journal:  Genes Cells       Date:  2002-03       Impact factor: 1.891

4.  RNA polymerase II C-terminal domain required for enhancer-driven transcription.

Authors:  H P Gerber; M Hagmann; K Seipel; O Georgiev; M A West; Y Litingtung; W Schaffner; J L Corden
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

5.  Threonine-4 of mammalian RNA polymerase II CTD is targeted by Polo-like kinase 3 and required for transcriptional elongation.

Authors:  Corinna Hintermair; Martin Heidemann; Frederic Koch; Nicolas Descostes; Marta Gut; Ivo Gut; Romain Fenouil; Pierre Ferrier; Andrew Flatley; Elisabeth Kremmer; Rob D Chapman; Jean-Christophe Andrau; Dirk Eick
Journal:  EMBO J       Date:  2012-05-01       Impact factor: 11.598

6.  The integrator complex recognizes a new double mark on the RNA polymerase II carboxyl-terminal domain.

Authors:  Sylvain Egloff; Sylwia Anna Szczepaniak; Martin Dienstbier; Alice Taylor; Sophie Knight; Shona Murphy
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

7.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.

Authors:  R Baskaran; M E Dahmus; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

Review 8.  Progression through the RNA polymerase II CTD cycle.

Authors:  Stephen Buratowski
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

Review 9.  "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions.

Authors:  Roberto Perales; David Bentley
Journal:  Mol Cell       Date:  2009-10-23       Impact factor: 17.970

10.  Functional unit of the RNA polymerase II C-terminal domain lies within heptapeptide pairs.

Authors:  John W Stiller; Matthew S Cook
Journal:  Eukaryot Cell       Date:  2004-06
View more
  3 in total

Review 1.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 2.  Tyrosine-1 and threonine-4 phosphorylation marks complete the RNA polymerase II CTD phospho-code.

Authors:  Martin Heidemann; Dirk Eick
Journal:  RNA Biol       Date:  2012-09-01       Impact factor: 4.652

Review 3.  Cross-talk of phosphorylation and prolyl isomerization of the C-terminal domain of RNA Polymerase II.

Authors:  S D Yogesha; Joshua E Mayfield; Yan Zhang
Journal:  Molecules       Date:  2014-01-27       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.